Status:
COMPLETED
Perioperative Immunonutrition in Patients Undergoing Gynecologic or General Elective Surgery (PURPOSE)
Lead Sponsor:
Hamilton Health Sciences Corporation
Conditions:
Surgical Site Infection
Post-Op Complication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the implementation pilot is to assess the practicality of introducing a perioperative immunonutrition protocol into a hospital environment as well as a true measure of impact on the r...
Detailed Description
Postoperative infectious complications are independently associated with increased hospital length of stay (LOS) and cost, and contribute to significant inpatient morbidity. Despite recent advances in...
Eligibility Criteria
Inclusion
- Men and women 18 years of age or older who are undergoing gynecologic oncology or general surgery (including resectable types of cancer) for which an elective operation is planned.
- Patients who are lactose intolerant are eligible for the study because the amount of lactose in INergy-FLD® is minimal (trace).
Exclusion
- Cannot tolerate enteral intake
- Organ failure (liver, kidney)
- Patients currently on steroids
- Female patients who are pregnant and/or lactating
- Galactosemia
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04057092
Start Date
August 1 2018
End Date
December 31 2020
Last Update
May 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Juravinski Cancer Centre
Hamilton, Ontario, Canada, L8V 1C3